




<rss xmlns:a10="http://www.w3.org/2005/Atom" version="2.0">
    <channel>
        <title>Atrial Fibrillation/Supraventricular Arrhythmias</title>
        <link>http://www.acc.org/Feed?clinicalTopicID=9d928ff7-0a69-4d5c-8ae4-9a5be446fc6b</link>
        <description>Clinical Topic Feed: Atrial Fibrillation/Supraventricular Arrhythmias</description>
        <language>en</language>

        

                <item>
                    <title>FinACAF: Stroke Risk Lower in AFL-Only vs. AFib-Only Patients</title>
<link>/Latest-in-Cardiology/Journal-Scans/2026/09/16/15/19/FinACAF</link>                    <description>Patients with atrial flutter only (AFL-only) had a 40% lower risk of ischemic stroke than those with atrial fibrillation only (AFib-only), based on results from the FinACAF study published Sept. 3 in EHJ.</description>
                    <pubdate>1789650840000</pubdate>
                    <category>Articles and Stories</category>
                </item>
                <item>
                    <title>Eagle&#226;€™s Eye View: Redefining CV Subspecialty Training</title>
<link>/Latest-in-Cardiology/Articles/2026/09/16/14/20/eagles-eye-view-16sep2026</link>                    <description>In this week&#226;€™s View, Dr. Eagle&#226;€&#175;looks at a recent article on proposed changes to the current cardiovascular (CV) subspecialty training path.</description>
                    <pubdate>1789568460000</pubdate>
                    <category>Articles and Stories</category>
                </item>
                <item>
                    <title>ACCEL Lite: Insights From the PVI-SHAM-AF</title>
<link>/Latest-in-Cardiology/Articles/2026/09/15/13/24/accel-lite-15sep2026</link>                    <description>In this episode, Clyde W. Yancy, MD, MACC and Rolf Wachter, MD discuss the results of &#226;€œPVI-SHAM-AF: Pulmonary vein isolation versus SHAM in AF&#226;€.</description>
                    <pubdate>1789479180000</pubdate>
                    <category>Articles and Stories</category>
                </item>
                <item>
                    <title>Novel LA Staging Framework Stratifies NOAF Risk in HCM</title>
<link>/Latest-in-Cardiology/Journal-Scans/2026/09/10/13/51/Novel-LA-Staging-Framework</link>                    <description>A novel left atrium (LA) staging framework proposed by Jaehyun Lim, MD, PhD, et al., was independently associated with a significant, stepwise increase in risk of new-onset atrial fibrillation (NOAF) in patients with hypertrophic cardiomyopathy (HCM), providing incremental predictive value beyond established atrial fibrillation (AFib) risk models, and may help tailor AFib surveillance strategies for these patients.</description>
                    <pubdate>1789054800000</pubdate>
                    <category>Articles and Stories</category>
                </item>
                <item>
                    <title>Eagle&#226;€™s Eye View: Top Trials from ESC 26</title>
<link>/Latest-in-Cardiology/Articles/2026/09/09/13/47/eagles-eye-view-09sep2026</link>                    <description>In this week&#226;€™s View, Dr. Eagle&#226;€&#175;looks at some of the important trials presented at this year&#226;€™s European Society of Cardiology (ESC) Congress.</description>
                    <pubdate>1788961680000</pubdate>
                    <category>Articles and Stories</category>
                </item>
                <item>
                    <title>Journal Wrap | Lifestyle Intervention Effective in Prediabetes; Aficamten Tops Metoprolol For Exercise in oHCM; More</title>
<link>/Latest-in-Cardiology/Articles/2026/09/01/01/Journal-Wrap</link>                    <description>The hottest research from various peer-reviewed journals &#226;€“ handpicked weekly by the ACC.</description>
                    <pubdate>1788264540000</pubdate>
                    <category>Articles and Stories</category>
                </item>
                <item>
                    <title>DISCO, LAACS-2, PRAGUE-26, HeartRunner: Insights on Cardiac Arrest, PE, and Surgical Outcomes</title>
<link>/Latest-in-Cardiology/Articles/2026/08/29/08/48/mon-902am-disco-laacs2-prague26-heartrunner-esc-2026</link>                    <description>Hot Line studies from ESC Congress 2026 highlight the complexity of improving cardiovascular outcomes, with new evidence refining the role of immediate coronary angiography after cardiac arrest, identifying which patients benefit from left atrial appendage (LAA) closure during cardiac surgery, advancing treatment options for pulmonary embolism (PE), and questioning the impact of community first-responder activation on short-term cardiac arrest survival.</description>
                    <pubdate>1788182580000</pubdate>
                    <category>Articles and Stories</category>
                </item>
                <item>
                    <title>ASPIRED, DANISH-CRT, and His-Alternative II Examine Syncope, CRT Strategies</title>
<link>/Latest-in-Cardiology/Articles/2026/08/29/08/48/mon-315am-comboep-esc-2026</link>                    <description>Three Hot Line trials from ESC Congress 2026 &#226;€“ ASPIRED, DANISH-CRT, and His-Alternative II &#226;€“ test 14-day ECG monitoring in patients with unexplained syncope, compare cardiac resynchronization therapy (CRT) modalities, and assess targeted left ventricular lead placement at the site of latest electrical activation in patients with heart failure and prolonged QRS.</description>
                    <pubdate>1788168300000</pubdate>
                    <category>Articles and Stories</category>
                </item>
                <item>
                    <title>ESC Releases New Guidelines For Cardiac Rehab, CKD and HF</title>
<link>/Latest-in-Cardiology/Articles/2026/08/29/08/48/mon-guidelines-esc-2026</link>                    <description>The European Society of Cardiology (ESC) released three major guideline updates during ESC Congress 2026 related to cardiac rehabilitation, chronic kidney disease (CKD) and heart failure (HF).</description>
                    <pubdate>1788164580000</pubdate>
                    <category>Articles and Stories</category>
                </item>
                <item>
                    <title>IDEAL-AF, NEXAF, PVI-SHAM-AF Provide New Evidence on Interventions That Could Improve AFib Management</title>
<link>/Latest-in-Cardiology/Articles/2026/08/29/08/48/sun-11am-comboaf-esc-2026</link>                    <description>Three new studies presented during ESC Congress 2026 are shedding light on how best to treat and manage atrial fibrillation (AFib). From catheter ablation strategies to rhythm-control procedures and tailored exercise programs, the IDEAL-AF, NEXAF and PVI-SHAM-AF trials provide fresh evidence on interventions that could improve outcomes and quality of life.</description>
                    <pubdate>1788102900000</pubdate>
                    <category>Articles and Stories</category>
                </item>

    </channel>
</rss>